NYSE · MTD
Healthcare · Medical - Diagnostics & Research
$1,674.81
Down-$43.80 (-2.55%)
Updated Oct 31, 2026, 4:14 AM
SID Score
6.0/10
Composite research score
Smart Money
58/100
Neutral
Price performance · MTD
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 30, 2026
MTD closed at $1,674.81 after 21 trading sessions, up 12.69% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 30, 2026 | $1,712.04 | $1,723.50 | $1,671.67 | $1,674.81 | 189.46K |
| Oct 29, 2026 | $1,702.80 | $1,728.66 | $1,696.27 | $1,718.61 | 129.41K |
| Oct 28, 2026 | $1,685.32 | $1,722.76 | $1,682.815 | $1,698.47 | 179.66K |
| Oct 27, 2026 | $1,664.22 | $1,692.985 | $1,648.36 | $1,685.32 | 140.97K |
| Oct 26, 2026 | $1,670.38 | $1,682.25 | $1,661.43 | $1,669.62 | 128.77K |
| Oct 23, 2026 | $1,678.04 | $1,686.975 | $1,652.975 | $1,670.29 | 199.33K |
| Oct 22, 2026 | $1,675.00 | $1,713.385 | $1,666.13 | $1,684.64 | 230.3K |
| Oct 21, 2026 | $1,606.00 | $1,681.26 | $1,606.00 | $1,677.94 | 140.31K |
| Oct 20, 2026 | $1,635.74 | $1,648.92 | $1,611.70 | $1,634.01 | 239.73K |
| Oct 19, 2026 | $1,632.23 | $1,642.00 | $1,619.995 | $1,625.73 | 135.79K |
| Oct 16, 2026 | $1,634.56 | $1,646.63 | $1,613.05 | $1,622.29 | 263.88K |
| Oct 15, 2026 | $1,620.00 | $1,659.70 | $1,609.45 | $1,639.04 | 260.09K |
| Oct 14, 2026 | $1,601.48 | $1,619.58 | $1,592.535 | $1,609.27 | 287.04K |
| Oct 13, 2026 | $1,587.74 | $1,604.3875 | $1,560.46 | $1,598.03 | 245.37K |
| Oct 12, 2026 | $1,559.13 | $1,568.48 | $1,549.78 | $1,563.01 | 188.12K |
| Oct 9, 2026 | $1,530.56 | $1,562.16 | $1,527.525 | $1,549.99 | 180.65K |
| Oct 8, 2026 | $1,521.56 | $1,536.54 | $1,500.90 | $1,529.46 | 264.56K |
| Oct 7, 2026 | $1,532.82 | $1,551.17 | $1,516.54 | $1,533.48 | 227.2K |
| Oct 6, 2026 | $1,560.00 | $1,585.72 | $1,512.52 | $1,533.07 | 196.05K |
| Oct 5, 2026 | $1,483.14 | $1,545.75 | $1,479.145 | $1,541.63 | 167.81K |
| Oct 2, 2026 | $1,491.84 | $1,501.90 | $1,480.15 | $1,486.19 | 129.33K |
The latest Smart Investors Daily articles mentioning MTD.
Company
Market Activity
Research & News
MTD research
Company profile and research snapshot.
Mettler-Toledo supplies weighing and precision instruments to customers in the life sciences (around 55% of sales), industrial (around 40%), and food retail (around 5%) industries. Its products include laboratory and retail scales, pipettes, pH meters, thermal analysis equipment, titrators, metal detectors, and X-ray analyzers. Mettler leads the market for weighing instrumentation and controls more than 50% of the market for lab balances. The business is geographically diversified, with the Americas accounting for about 37% of sales, Europe about 28%, China about 16% and the rest of the world about 19%.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Oct 13, 2026 | Morgan Stanley | Equal-Weight | — |
| Oct 7, 2026 | Barclays | Overweight | — |
| Sep 2, 2026 | Rothschild & Co | Sell | — |
| Sep 1, 2026 | RBC Capital | Sector Perform | — |
| Aug 4, 2026 | Morgan Stanley | Equal-Weight | — |
No generated briefing is available yet.
Yahoo · Oct 24, 2026
Over the past six months, Mettler-Toledo has been a great trade, beating the S&P 500 by 24.1%. Its stock price has climbed to $1,685, representing a healthy 33.3% increase. This was partly thanks to its solid quarterly results, and the performance may have investors wondering how to approach the situation.
Yahoo · Oct 23, 2026
Mettler-Toledo International (MTD) comes into focus after a run of earnings surprises, with an average 4.36% beat and a current Earnings ESP of +0.10% ahead of its expected November 5, 2026 report. Mettler-Toledo International’s recent earnings optimism sits alongside strong price momentum, with a 13.01% 1 month share price return, a 26.93% 3 month share price gain and a 17.17% 1 year total shareholder return, suggesting that confidence has been building rather than fading. Scan beyond...
Yahoo · Oct 22, 2026
Mettler-Toledo (MTD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Benzinga · Oct 13, 2026
Morgan Stanley analyst Kallum Titchmarsh maintains Mettler-Toledo Intl (NYSE:MTD) with a Equal-Weight and raises the price target from $1450 to $1575.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning MTD.
